Research Webinar Series: UCB Generalized Myasthenia Gravis

Presented by: Christyn Edmundson, MD
Thursday May 16th, 4:30PM EST
UCB is proud to have Christyn Edmundson, MD share educational information about a targeted treatment with the MGFA gMG community. The webinar will include key details about an FDA-approved treatment for adults with gMG who are anti-AChR (acetylcholine receptor) antibody positive, including how it works, what patients and caregivers can expect with this treatment, and helpful points for how to talk with a doctor about gMG symptoms and treatment.
____________________________
This information is not intended to replace discussions with your healthcare provider.
This, “Targeted Treatment for Generalized Myasthenia Gravis”, Webinar is sponsored by UCB, and content is valid as of the live date: August 2nd, 2024.
Dr. Christyn Edmundson, MD has been compensated for the presentation of this information.
Dr. Edmundson is Site Director of the Neurology clerkship at the Swedish Neuroscience Institute. 
MGFA is providing this resource as an educational opportunity for the neuromuscular disease community.
This program is not sponsored, endorsed, or accredited by MGFA.